Coexistence of malignant struma ovariiwith abdominal wall metastasis and cervical papillary thyroidcarcinoma with RET/PTC۱ rearrangement

سال انتشار: 1402
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 55

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

CGC01_265

تاریخ نمایه سازی: 29 آبان 1402

چکیده مقاله:

Introduction: Struma ovarii is a mature cystic teratoma composedpredominantly or entirely of thyroid tissue (≥۵۰%).Struma ovarii is a rare medical condition, and malignant transformationis even rarer. The coexistence of malignant strumaovarii and cervical thyroid carcinoma is also scarce, with datainsufficiency in molecular analysis. Here, we described the firstreport of coexistent malignant struma ovarii with abdominalwall metastasis and cervical papillary thyroid carcinoma withRET/PTC۱ rearrangement.Methods: A ۴۷-year-old multigravida woman with abnormaluterine bleeding was referred, and the evaluations revealedbilateral adnexal and lower abdominal wall masses. Then, ahysterectomy, bilateral salpingo-oophorectomy, and surgicalremoval of the abdominal wall mass were performed. Furthermore,a nodule within the left lobe of the cervical thyroid glandwas located during examination and ultrasound. Consequently,the patient underwent a total thyroidectomy. Finally, samplesof all affected tissue, including adnexal and abdominal wallmasses and cervical thyroid gland, were examined for BRAFV۶۰۰E, N-RAS, and RET/PTC۱ rearrangement. Then, the patientwas followed for six years after receiving radioactive iodineablation.Results: In histopathological evaluations, papillary thyroid carcinoma(PTC) was found within struma ovarii, and metastaticPTC was located in the abdominal wall fibro adipose tissue.Moreover, the cervical thyroid gland pathological examinationillustrated bilateral and multifocal PTC. Furthermore, RET/PTC۱ rearrangement was detected in the PTC arising in strumaovarii, abdominal wall metastasis, and cervical thyroid gland.Finally, six years of follow-up showed no evidence of recurrenceor distant metastasis.Conclusion: In light of these findings, considering suspectedcervical thyroid carcinoma while diagnosing malignant strumaovarii might be beneficial. In addition, according to the rarityof concurrent development of malignant struma ovarii andcervical thyroid carcinoma, the molecular investigation couldyield valuable results to explain the underlying mechanism ofcoexisting conditions, the tumor’s malignant behavior, and thepatient’s prognosis.

نویسندگان

Maryam Kabootari

Metabolic Disorders Research Center, Golestan University ofMedical Sciences, Gorgan, Iran.Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University ofMedical Sciences, Tehran, Iran

Reza Habibi Tirtashi

Metabolic Disorders Research Center, Golestan University ofMedical Sciences, Gorgan, Iran.

Maryam Zarkesh

Cellular and Molecular Endocrine Research Center, ResearchInstitute for Endocrine Sciences, Shahid Beheshti University ofMedical Sciences, Tehran, Iran

Hossein Samadanifard

Cellular and Molecular Endocrine Research Center, ResearchInstitute for Endocrine Sciences, Shahid Beheshti University ofMedical Sciences, Tehran, Iran

Fereidoun azizi

Department of Endocrinology, School of Medicine, Hazrat-e RasoolHospital, Iran University of Medical Sciences. Tehran, Iran

azita Zadeh- Vakili

Endocrine Research Center, Research Institute for EndocrineSciences, Shahid Beheshti University of Medical Sciences, Tehran,Iran